Related Experiment Video
Updated: Apr 25, 2026

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
Published on: April 5, 2024
miRNAs in tumor radiation response: bystanders or participants?
Paolo Gandellini1, Tiziana Rancati2, Riccardo Valdagni3
1Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Abstract:
There is increasing interest in defining a functional association between miRNAs and tumor radiation response, with the double aim of rationally designing miRNA-based strategies to increase patient radiosensitivity and identifying novel biomarkers of treatment response. Although it has been demonstrated that several miRNAs directly regulate the expression of components of cell pathways relevant to radiosensitivity, and miRNA expression profiles change upon irradiation, understanding the causal role exerted by individual miRNAs in determining tumor radiation response is still at an early stage. Based on available experimental and clinical evidence, we discuss here the potential of miRNAs as targets and/or tools for modulating radioresponsivity at the clinical level, as well as possible predictive biomarkers, underlining present limits and future perspectives.
Insights
MicroRNAs (miRNAs) show promise in improving tumor radiation response and identifying biomarkers. Further research is needed to understand their causal roles in radiosensitivity for clinical applications.
Area of Science:
- Oncology
- Molecular Biology
- Radiotherapy
Background:
- Increasing interest in microRNAs (miRNAs) and their role in tumor radiation response.
- miRNAs regulate pathways crucial for radiosensitivity and their expression changes upon irradiation.
- The causal role of individual miRNAs in tumor radiosensitivity is not fully understood.
Purpose of the Study:
- To explore the potential of miRNAs as targets and tools for modulating radioresponsivity.
- To identify miRNAs as predictive biomarkers for treatment response.
- To discuss current limitations and future directions in miRNA-based cancer therapy.
Main Methods:
- Review of available experimental evidence.
- Analysis of clinical data on miRNA expression and radiation response.
- Discussion of miRNA-based strategies for enhancing radiosensitivity.
Main Results:
- Several miRNAs directly regulate key components of radiosensitivity pathways.
- miRNA expression profiles are altered following radiation exposure.
- miRNAs hold potential as both therapeutic tools and predictive biomarkers.
Conclusions:
- miRNAs offer potential for designing novel radiosensitizing strategies.
- miRNAs can serve as predictive biomarkers for patient response to radiotherapy.
- Further investigation is required to elucidate the precise causal roles of miRNAs in radioresponsivity.
Related Concept Videos
Other Unique Bacteria
Biological Effects of Radiation

